Connect with us

Business

Where to Watch Livestream as Prosecutors Are Expected to Rest Their Case

Published

on

Lindsay Clancy Trial Day 14: Where to Watch Livestream as

PLYMOUTH, Mass. — The murder trial of Lindsay Clancy, the Duxbury mother accused of killing her three young children in January 2023, entered its 14th day of testimony Monday in Plymouth Superior Court, with Judge William Sullivan telling jurors that prosecutors are expected to formally rest their case during the session.

“It’s anticipated that the Commonwealth will close their portion of the evidence today,” Sullivan told jurors Monday morning, according to court reporting. “Then at that point, the defendant has the opportunity, if they want to, to present witnesses and evidence if they want to.”

The trial has generated intense public interest and has been livestreamed throughout its run, with coverage available through several Massachusetts news outlets including Boston 25 News, CBS Boston and ABC7, all of which have provided ongoing livestream access and real-time updates from inside the courtroom. Journalists and members of the public have packed the courtroom itself throughout the proceedings, while online audiences have closely followed developments as the case has unfolded.

Advertisement

Clancy, 36, faces first-degree murder charges in the deaths of her three children — 5-year-old Cora, 3-year-old Dawson and 8-month-old Callan — who died at the family’s Duxbury home on Jan. 24, 2023. Clancy has pleaded not guilty. Her attorneys do not dispute that she killed the children, but argue she should not be held criminally responsible because she was suffering from postpartum psychosis at the time and believed she was hearing voices instructing her to take the children’s lives and her own.

Prosecutors have presented a different account, arguing that Clancy acted with intent and premeditation. According to prosecutors, Clancy arranged to have her husband, Patrick, leave the house to pick up takeout food and visit a pharmacy on the day of the killings, then strangled the children with resistance exercise bands while he was away. Prosecutor Shanan Buckingham has urged jurors to evaluate the case on its facts rather than as a broader referendum on mental health treatment, telling the court the trial should not be viewed as “a public debate about women’s mental health and how the medical system treats women.”

The trial’s 13th day of testimony, held Thursday, included Massachusetts State Police investigators walking jurors through forensic analysis of Clancy’s cellphone, part of the prosecution’s broader effort to establish a timeline and pattern of behavior leading up to the killings. During cross-examination that day, defense attorney Kevin Reddington highlighted internet search history from a family computer, including searches related to psychiatric medication and mental health terms conducted in the weeks before the killings, though ownership and authorship of some searches remained disputed between the two sides during testimony.

The trial’s proceedings the day before, on Wednesday, were described as particularly difficult, with jurors shown autopsy photographs and hearing graphic testimony regarding injuries suffered by Clancy’s two oldest children. That testimony reportedly prompted Clancy to become emotional in the courtroom, at one point telling the court, “I can’t do this,” according to reporting from the trial.

Advertisement

A legal analyst who has followed the proceedings has suggested that Clancy’s emotional reactions during testimony could influence how jurors ultimately perceive her state of mind, both at the time of the killings and throughout the trial itself, a factor that may play into the jury’s eventual determination regarding her criminal responsibility.

Prosecutors have sought throughout the trial to demonstrate that Clancy had access to a range of mental health resources and treatment options but did not consistently follow medical guidance, including discontinuing certain prescribed medications. Several of Clancy’s treating medical providers have testified for the prosecution, telling jurors that Clancy never discussed having a specific plan to harm herself or her children during their sessions with her, and that she did not display outward signs consistent with psychosis or mania, despite having reported experiencing suicidal thoughts to some providers.

The defense, led by Reddington, has maintained since early in the case that Clancy had been prescribed as many as a dozen different medications following the birth of her third child and that resulting over-medication, which Reddington has previously described as “horrific,” significantly contributed to her mental state at the time of the killings. The defense has argued this amounted to postpartum psychosis severe enough that Clancy should not be held criminally responsible for her actions under Massachusetts law.

According to prosecutors’ account presented at Clancy’s initial arraignment, after the killings, Clancy attempted to take her own life by cutting her wrist and neck before jumping from a second-story window of the family home. She survived but sustained injuries that left her permanently paralyzed from the waist down. She has remained hospitalized, primarily at Tewksbury Hospital, throughout much of the period since her arrest and has appeared at various pretrial hearings via video conference due to her medical condition.

Advertisement

Clancy’s case has drawn extensive pretrial litigation over the more than three years since the killings, including disputes over medical records, expert witness materials and reporting notes from a New Yorker journalist who had interviewed Patrick Clancy regarding his wife’s mental health prior to the killings. The trial itself was postponed multiple times before ultimately beginning this summer.

Clancy’s parents, Mike and Paula Musgrove of Wallingford, Connecticut, have continued to publicly support their daughter throughout the legal proceedings. “She’s a loving mother, always has been,” Paula Musgrove told reporters outside the courtroom during an earlier hearing, while her husband added, “We love our daughter very much, and we’re here just to support her any way we possibly can.”

With prosecutors expected to conclude their case Monday, attention now turns to whether the defense will call its own witnesses, including any mental health experts expected to testify regarding Clancy’s psychiatric state at the time of the killings. No timeline has been announced for how long the defense’s portion of the trial might take, and Judge Sullivan has not indicated when the case might ultimately go to the jury for deliberation.

This story involves themes of suicide, mental illness and violence toward children, which can be difficult to read about. If you or someone you know is experiencing a mental health crisis, thoughts of suicide, or postpartum depression or psychosis, you can call or text 988 or chat at 988lifeline.org, available 24/7.

Advertisement
Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Crowley retires as PwC’s WA head

Published

on

Crowley retires as PwC’s WA head

Big four accounting firm PwC’s Perth managing partner Martina Crowley will be retiring from the firm in November after three years in the top Western Australian position.

Continue Reading

Business

Backing for Amazon MGM Studios’ plan for Bray Film Studios

Published

on

A CGI-generated image of two rowers rowing past Bray Studios.

Amazon MGM Studios’ planned expansion of a Berkshire-based complex would be a “considerable boost” for filmmaking, a government-funded industry body said.

Bray Film Studios, in Water Oakley, near Windsor, was previously used by the Hammer Films company.

The previous owner of the studios got planning permission to expand them in 2022 and Amazon MGM bought the site in 2024.

The British Film Commission (BFC) said it “recognises that the studio benefits from Amazon MGM’s commitment” and welcomed its “ambition to support employment opportunities for both the local community and more widely across the UK sector”.

Advertisement

The company has been using the site since 2022 and a public consultation regarding the expansion project closed in May.

Amazon MGM said its current proposals, which include building a multi-storey car park and six new sound stages, would help “realise the site’s full potential”.

The expansion is expected to create 470 jobs as it is built and 920 in Berkshire more widely.

Samantha Perahia, the BFC’s head of production, told the Royal Borough of Windsor and Maidenhead that it supports the plan.

Advertisement

“The enhancements proposed for Bray Studios will not only allow the region to build on its already established and impressive reputation amongst international clients,” she said.

She added that it “would also provide a considerable boost to the combined efforts of the BFC and our public and commercial partners in marketing the region, and the wider UK.”

The planning application will be decided later.

Advertisement
Continue Reading

Business

SK Hynix’s U.S.-Listed Shares Jump 4% as AI Memory Rally Continues Despite Choppy Trading This Year

Published

on

SK Hynix ADR Plunges Nearly 8% to $162 as Wild

SEOUL — Shares of SK Hynix’s U.S.-listed American depositary receipts climbed 4.12%, or $6.86, to $173.19 as of 9:59 a.m. EDT Monday, extending a volatile but broadly upward run for the South Korean memory chipmaker as investor enthusiasm for artificial intelligence-driven memory demand continued to reassert itself following weeks of sharp swings.

Monday’s gain came amid renewed optimism tied to expanding AI memory demand, according to market analysis, with the stock benefiting from broader momentum across the semiconductor sector as investors continued positioning around companies seen as key suppliers to the ongoing AI infrastructure buildout.

The rally builds on a dramatic run for SK Hynix’s ADRs since their debut on Wall Street in July. The company priced its initial offering of 177.9 million ADRs at $149 each, raising proceeds of $26.5 billion in what became the largest-ever initial share sale in the United States by a foreign company. The shares opened at $170 on their first day of trading and closed that session at $168.01, up 12.8% from the offering price, reflecting immediate and substantial investor demand for exposure to the memory chipmaker.

Since that debut, however, SK Hynix’s American shares have traded with significant volatility. According to market tracking data, the stock closed near $169.50 on July 23 before sliding into the low $140s by Aug. 11, then rebounding sharply back above $170 by Aug. 14. That pattern of steep declines followed by rapid recoveries has continued into this week, with the stock’s swings tied closely to headlines regarding the company’s various AI infrastructure partnerships and broader sentiment shifts across AI-linked technology stocks.

Advertisement

Much of that volatility has centered on a massive infrastructure partnership SK Hynix entered alongside Nvidia and its parent company, SK Group. The companies signed a partnership valued at more than $500 billion focused on AI infrastructure, under which SK Hynix locked in a long-term deal to co-develop next-generation high-bandwidth AI memory and support a 2-gigawatt AI cloud buildout in South Korea. Despite the scale and strategic significance of the agreement, SK Hynix shares initially sold off sharply on the announcement, falling as much as 8.8% to 10% in a single session, reflecting a pattern in which investors have periodically taken profits on positive news given how far and fast the stock had already climbed.

SK Hynix has continued expanding its manufacturing footprint to keep pace with surging demand. The company announced plans to invest 54 trillion Korean won, or approximately $38.1 billion, to build two new memory chip manufacturing plants — one in Yongin, referred to as “Y2,” and another in Cheongju, referred to as “M17” — as demand for components critical to AI applications continues to outstrip available supply. Neil Shah, vice president of research and co-founder of Counterpoint Research, said the investment reflects a longer-term strategic response rather than an immediate production shift. “This has prompted SK Hynix to inject fresh capex to expand its footprint. In the near term, this won’t alter SK Hynix’s output but is built for 2029 and beyond,” Shah said, adding that expansions from Samsung, SK Hynix, Micron and China’s CXMT are expected to meaningfully increase global memory supply through 2028.

SK Hynix has separately announced plans to resume construction of its second NAND memory plant in Dalian, China, targeting roughly 50% output growth at that facility, a move that contributed to a 3.2% jump in the stock that helped it lead gains among peers valued above $200 billion.

The company’s push into the U.S. market comes as America represents SK Hynix’s largest single market, accounting for 68.8% of its revenue last year. The company is planning to build its first U.S. production facility in Indiana as part of its broader expansion strategy. SK Hynix generated just under $65 billion in revenue in 2025, with profits doubling to roughly $28 billion, a turnaround the company has attributed largely to soaring demand for high-bandwidth memory chips used in AI processors, including chips supplied to Nvidia.

Advertisement

Wall Street analysts have remained broadly bullish on SK Hynix’s prospects despite the stock’s recent volatility. In the weeks following the company’s public listing, Goldman Sachs raised its price target on SK Hynix’s Korean-listed shares to 290,000 won, implying a potential gain of roughly 25% from the stock’s trading level at the time the target was issued. Citigroup went further, raising its target to 350,000 won, more than 50% above the stock’s trading level at the time. Nineteen analysts revised their forecasts upward for SK Hynix in the month leading up to those target increases, according to data compiled by Bloomberg, driven largely by anticipation of continued strong earnings tied to AI-related memory demand.

Some investors have expressed caution given how significantly the stock has already appreciated. SK Hynix has traded at as much as 2.9 times book value, a level not seen since at least 2011, raising questions among some market participants about how much additional upside remains priced into the stock at current valuations. According to fundamental data cited by market analysts, SK Hynix currently carries an enterprise value of approximately $1.21 trillion and a leverage ratio of 1.5, alongside a one-year return on invested capital of 73.54%, figures that underscore both the scale of investor enthusiasm surrounding the stock and the increasingly demanding performance bar the company faces going forward.

Reports of fresh institutional investment have also contributed to recent gains. News of funding interest from Singapore’s Temasek in both SK Hynix and Samsung reportedly drove a 4.6% single-day gain in SK Hynix shares, signaling what analysts described as rising institutional appetite for exposure to Korean memory chipmakers amid the broader AI infrastructure buildout.

With memory prices continuing to rise amid persistent supply shortages, SK Hynix, Samsung and Micron have all seen substantial share-price rallies over the past year as investors bet that the current imbalance between memory chip supply and AI-driven demand will persist for an extended period. Whether that dynamic continues to support SK Hynix’s valuation, or whether expanding global memory supply eventually catches up with demand as new manufacturing capacity comes online later this decade, is likely to remain one of the central questions shaping investor sentiment toward the stock in the months ahead.

Advertisement
Continue Reading

Business

Duos Technologies Group, Inc. (DUOT) Q2 2026 Earnings Call Transcript

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript